Skip to main content
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. — Investor Relations & Filings

Ticker · SCNX ISIN · US89846A2078 US Manufacturing
Open in API
Filings indexed 495 across all filing types
Latest filing 2009-08-11 Regulatory Filings
Country US United States of America
Listing US SCNX

About Scienture Holdings, Inc.

https://www.trxadehealth.com/

Scienture Holdings, Inc. is a holding company that operates through its subsidiaries, including Scienture, LLC and Integra Pharma Solutions, LLC. The company functions as an integrated pharmaceutical and health services provider focused on the development, commercialization, and distribution of novel specialty products. A key therapeutic area includes treatments for central nervous system disorders. Scienture Holdings aims to enhance value for patients and physicians by addressing the needs of underserved populations and bridging gaps in treatment delivery systems to improve healthcare outcomes. The company also provides a web-based purchasing platform for transactions.

Recent filings

Filing Released Lang Actions
XCELLINK 8K 081109
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 11, 2009, reporting a material definitive agreement (a share exchange agreement) and other corporate events such as a change of office address and share return to treasury. It does not contain financial statements or detailed financial performance data. The content is typical of a current report disclosing significant corporate events rather than a full annual or quarterly report. Therefore, it fits the category of a Regulatory Filing (RNS), which is the fallback for miscellaneous SEC filings that do not fit other specific categories.
2009-08-11 English
XCELLINK 10Q 033109
Interim / Quarterly Report Q1 2009
2009-05-20 English
XCELLINK NT 10Q 033109
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 filed with the SEC, which is a Notification of Late Filing. It specifically states that the company, Xcellink International, Inc., is notifying the SEC that it could not file its quarterly report on Form 10-Q for the period ended March 31, 2009 on time and requests an extension. The document does not contain the actual financial statements or substantive financial data of the 10-Q report but is rather a notification about the delay in filing that report. According to the rules, such a notification is a Regulatory Filing (RNS) because it is a compliance document related to filing deadlines and does not contain the report itself.
2009-05-15 English
XCELLINK - 8K 043009 - LIC AGREE, MALBOURNE
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 27, 2009. It reports the entry into a material definitive agreement (a license agreement), appointment of a new director and officer, and a change of the company's head office address. The content focuses on corporate governance changes and business operations updates rather than financial results or detailed financial statements. The document is about announcements of corporate events and management changes rather than a full financial report or earnings release. Therefore, the most appropriate classification is 'MANG' for Board/Management Information, as it includes appointment of a director and officer and other management-related updates.
2009-04-30 English
EXCELLINK 10K 123108
Annual Report FY 2008
2009-04-15 English
Regulatory Filings 2009
Regulatory Filings
2009-03-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.